We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Nebivolol on Central Aortic Pressure

This study has been withdrawn prior to enrollment.
(Similar study already published)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01051947
First Posted: January 20, 2010
Last Update Posted: August 1, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Creighton University
January 19, 2010
January 20, 2010
August 1, 2011
December 2009
May 2010   (Final data collection date for primary outcome measure)
Stable blood pressure [ Time Frame: 6 months ]
Subjects will be randomized to nebivolol or metoprolol. Their medication will be titrated so that their blood pressure is within 10% of their initial reading.
Not Provided
Complete list of historical versions of study NCT01051947 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Impact of Nebivolol on Central Aortic Pressure
Impact of Nebivolol on Central Aortic Pressure
A randomized, cross-over, single-blind study to compare the effects of nebivolol and metoprolol on central aortic pressure and peripheral brachial pressure in patients with stable cardiovascular disease.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Central Aortic Pressure
  • Drug: Nebivolol
    10 mg by mouth daily for 2 weeks 20 mg by mouth daily for 2 weeks 40 mg by mouth daily for 2 weeks
  • Drug: Metoprolol
    dosage prescribed prior to starting on study
  • Experimental: Nebivolol
    Nebivolol therapy for 2-6 weeks depending on blood pressure readings
    Intervention: Drug: Nebivolol
  • Experimental: Metoprolol
    Metoprolol therapy for 2-6 weeks depending on blood pressure readings
    Intervention: Drug: Metoprolol
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
May 2010
May 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects with history of hypertension
  • Subjects who have received metoprolol for a minimum of 3 months

Exclusion Criteria:

  • Patients who have had an acute myocardial infarction, coronary revascularization or who have been hospitalized for heart failure or cardiac arrhythmia in the past 6 months
Sexes Eligible for Study: All
45 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01051947
08-15168
No
Not Provided
Not Provided
Jennifer Campbell, PharmD, Creighton University
Creighton University
Not Provided
Principal Investigator: Jennifer Campbell, PharmD Creighton University
Creighton University
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP